Investment to help address new opportunities, says Kantipudi Goldman Sachs, an active investor in India having deployed more than US$3.6 billion, has taken a significant minority stake in Aragen Life Sciences, formerly known as GVK Biosciences and a leading contract...
Read moreDetails










